Motley Fool Staff

A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?

Author Andy Hoffman helps us think about the role of business.

Sem Verbeek is a man of many talents, on and off the court.

529 plans aren't just for college anymore.

Have you started thinking yet about when you'll start taking Social Security?

Grab the popcorn -- this mailbag goes well beyond beach talk.

The Federal Reserve holds rates steady for now, but an ever-evolving trade and tariff picture raises questions about for how long. Also, Meta Platforms and Microsoft earnings suggest no slowdown in AI spending.

The Fed kept rates flat, Apple and Amazon reported earnings, and we have the biggest names in AI battle it out for supremacy.

The former Chip King is cutting again in hopes of finding a path to sustainable growth.

Between battered industries and overlooked opportunities, plenty of dividend-paying companies have slipped.

The U.S. and Japan announced a big trade deal that lowers tariffs to just 15% on imports, and the team discusses earnings from General Motors, Intuitive Surgical, and Enphase Energy.

Meme stocks had a huge week; earnings season got into full swing with Alphabet going big on AI.

With Block joining the S&P 500 and Figma debuting, investors may be wondering if they should be rising with the tide or fishing where others are not.

Reports from Starbucks, Visa, and Spotify give us a read on the consumer, and Samsung takes a big chip order from Tesla.

A set of AI use cases within the medical space.

Christine Benz is the director of personal finance at Morningstar and the author of "How to Retire: 20 Lessons for a Happy, Successful, and Wealthy Retirement."

Earnings season is rolling along!